secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001213900-23-075416
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Phoenix Biotech receives Nasdaq deficiency notice for minimum public holders rule
--------------------------------------------------------------------------------

- Received Nasdaq notice on Sep 7, 2023, for non-compliance with Minimum Public Holders Rule (400 public holders required for Nasdaq Global Market).
- Has 45 calendar days to submit a plan to regain compliance; intends to submit within timeframe.
- If plan accepted, Nasdaq may grant up to 180-day extension; if rejected, can appeal to Hearings Panel.
- Also pursuing a business combination with CERo Therapeutics (previously filed Form S-4).
- Notice is not an imminent delisting; no current effect on listing or trading of PBAX securities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390023075416/0001213900-23-075416-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390023075416/ea184886-8k425_phoenix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-075416

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer